cl 387785 has been researched along with pd168393 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, R; DeBlanc, R; Discafani, C; Greenberger, LM; Gruber, BC; Johnson, BD; Koehn, FE; Mamuya, N; Nilakantan, R; Reich, MF; Shen, R; Tsou, HR; Wang, YF; Wissner, A; Ye, F | 1 |
Da Settimo, F; La Motta, C; Martinelli, A; Nerini, E; Sartini, S; Tuccinardi, T | 1 |
Barf, T; Kaptein, A | 1 |
1 review(s) available for cl 387785 and pd168393
Article | Year |
---|---|
Irreversible protein kinase inhibitors: balancing the benefits and risks.
Topics: Animals; Cell Line; Humans; Protein Kinase Inhibitors; Protein Kinases; Risk; Structure-Activity Relationship; Time Factors | 2012 |
2 other study(ies) available for cl 387785 and pd168393
Article | Year |
---|---|
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Blotting, Western; Cell Division; Drug Screening Assays, Antitumor; Enzyme Inhibitors; ErbB Receptors; Female; Fluorometry; Glutathione; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Nude; Models, Molecular; Phosphorylation; Precipitin Tests; Quinazolines; Receptor, ErbB-2; Transplantation, Heterologous; Tumor Cells, Cultured | 2001 |
Computational studies of epidermal growth factor receptor: docking reliability, three-dimensional quantitative structure-activity relationship analysis, and virtual screening studies.
Topics: Computational Biology; Computer Simulation; Databases, Protein; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Protein Binding; Quantitative Structure-Activity Relationship | 2009 |